Mayne Pharma / TWYNEO Cream
An approved acne cream that shows why compatibility depends on the finished product. The current label also makes storage dates unusually important and contains a trial-table discrepancy worth preserving in the record.
Worth buying for a specific person with a specific problem. Read who.
ASSESSED ON 15% OF THE MODEL. 5 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
Treatment requires an individual prescription. Confirm the full cost and follow-up arrangements before paying.
Salicylic acid, zinc oxide, niacinamide and urea for blemishes and congestion. From $42 / month advertised.
VIEW Pore FavorREAD OUR REVIEWThe verdict
The formulation is the key fact: each active is separately microencapsulated. This is evidence against a blanket rule that tretinoin and benzoyl peroxide can never coexist; it is not a recipe for mixing separate products.
The current manufacturer label identifies Mayne Pharma and a 30 g pump. We use its current handling instructions and flag its inconsistent Trial 1 success row instead of silently choosing the most favorable number.
- Defined antibiotic-free retinoid/BPO combination.
- Finished-product trials and specific handling instructions are public.
- Current trial-table numbers contain an unresolved inconsistency.
- The opening and dispensing clocks can shorten usable time.
- No patient-specific price or tolerability was established.
Every active, assessed
- Tretinoin0.1%
Prescription treatment component
- BENCHMARK
- Exact product, indication and vehicle
- ASSESSMENT
- Separately encapsulated in the finished cream; not interchangeable with an arbitrary 0.1% tretinoin product.
- Benzoyl peroxide3%
Prescription treatment component
- BENCHMARK
- Exact product, indication and vehicle
- ASSESSMENT
- Part of the tested combination, not an instruction to add a separate layer.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| TretinoinPrescription treatment component | 0.1% | Exact product, indication and vehicle | Separately encapsulated in the finished cream; not interchangeable with an arbitrary 0.1% tretinoin product. |
| Benzoyl peroxidePrescription treatment component | 3% | Exact product, indication and vehicle | Part of the tested combination, not an instruction to add a separate layer. |
Scoring
- EVIDENCE FOR THE ACTIVEWEIGHT 30%NOT ASSESSED
Ingredient background is discussed separately. No performance score is assigned to an untested service or to a prescription that varies by patient.
- FORMULATION INTEGRITYWEIGHT 20%NOT ASSESSED
The exact dispensed preparation, manufacturer or patient-specific base was not inspected.
- DISCLOSUREWEIGHT 15%80/100
A full label is available, but the current Table 4 Trial 1 success rate does not reconcile with its reported difference. No chart or product ranking is built from that row.
- TOLERANCE IN USEWEIGHT 15%NOT ASSESSED
No patient panel or personal treatment course. Cannot infer tolerability from ingredient names or testimonials.
- TEXTURE & WEARWEIGHT 10%NOT ASSESSED
No product-in-hand testing.
- COST PER APPLICATIONWEIGHT 10%NOT ASSESSED
Published fees are compared in the text. Actual dispensed quantity, application amount and usable duration are needed for this criterion.
Open the review comparison tray →
Compatibility is a formulation question
TWYNEO contains tretinoin 0.1% and benzoyl peroxide 3%, separately microencapsulated using silica structures. It is approved for acne from age 9. That finished formulation is the relevant unit of evidence. It does not establish the stability or tolerance of separately purchased products mixed together.
A trial row we have not turned into a chart
The current manufacturer's Table 4 prints Trial 1 success as 33.9% versus 14.3%, alongside a stated difference of 25.7 percentage points. Those figures do not reconcile. The original FDA approval label prints 39.9% versus 14.3%. We retain both sources and leave this row out of the evidence chart while the discrepancy remains unresolved.
This is a documentation problem, not proof that the medicine fails. Readers should be able to see uncertainty before a number becomes a ranking. The trials used a vehicle comparator; even a reconciled table would not establish superiority over CABTREO, a compounded cream or separate prescriptions.
Two dates govern the remaining cream
The current label says to discard at 12 weeks after dispensing or 60 days after opening, whichever is earlier, and to keep it at 20–25°C without freezing. These limits matter when comparing a price per gram. Ask the pharmacist to mark both dates and clarify instructions for your dispensed pack.
A clinician still needs the whole routine
Tell the prescriber about other acne treatments and prior benzoyl-peroxide reactions. An integrated combination is not automatically gentle or appropriate for everyone. Read the complete patient information for irritation, sun-protection and allergy precautions, and ask how to respond if the treatment is not tolerated.
Who this is for
- Someone discussing an antibiotic-free topical combination for acne with a clinician.
- You have a serious benzoyl-peroxide allergy.
- You want to mix separate products to recreate the formulation.
- You need evidence for wrinkle treatment rather than acne.
Treatment requires an individual prescription. Confirm the full cost and follow-up arrangements before paying.
Salicylic acid, zinc oxide, niacinamide and urea for blemishes and congestion. From $42 / month advertised.
VIEW Pore FavorREAD OUR REVIEWThis is an editorial assessment of published information about aprescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01TWYNEO — current manufacturer prescribing information February 2025 label names Mayne Pharma and a 30 g pump. Trial 1 success and difference figures in Table 4 conflict; that row is not charted here. Storage limits are product-specific. Checked 13 September 2026.
- S-02FDA — original TWYNEO approval label Historical 2021 label used only to investigate the Trial 1 table discrepancy. Its older pack size and opening limit are not used for current purchasing advice. Checked 13 September 2026.